Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $11.26M.
ENTERPRISE VALUE (EV)
$11.26M
Biofrontera Inc.
Market Cap
$11.82M
Enterprise Value (EV)
$11.26M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Biofrontera Inc. (BFRI) | $11.82M | $11.26M |
| Phio Pharmaceuticals Corp. (PHIO)vs › | $11.73M | N/A |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.30M | $4.56M |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $11.94M | $5.11M |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $11.28M | N/A |
| BioVie Inc. (BIVI)vs › | $11.20M | $2.50M |
| Pluri Inc. (PLUR)vs › | $11.17M | $42.56M |
| IRIDEX Corporation (IRIX)vs › | $12.12M | $11.45M |
| CytoMed Therapeutics Limited (GDTC)vs › | $10.94M | $10.16M |
| Lisata Therapeutics, Inc. (LSTA)vs › | $10.93M | $484668.00 |
Market Cap
$11.82M
Total Debt
$5.83M
Cash
$6.39M
Enterprise Value
$11.26M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
